1Wilson FM. Adverse external ocular effects of topical ophthalmic therapy: an epidemiological, laboratory and clinical study. Trans Am Ophthalmol Soc,1983,81:854-965.
2Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc, 2001,99:205-212.
3Lin JC, Rapuano CJ, Laibson PR, et al. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol,2000,118:1129-1132.
4Pouliquen Y, Patey A, Foster CS,et al. Drug induced cicatrical pemphigoid affecting the conjunctiva. Light and electron microscopic features. Ophthalmology,1986,93:776-783.
5Scuderi AC, Paladino GM, Marino C,et al. In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells. Cornea,2003,22:468-472.
6Mallari PL, McCarty DJ, Daniell M,et al. Increased incidence of corneal perforation after topical fluroquinolone treatment for microbial keratitis. Am J Ophthalmol, 2001,131:131-133.
7Broadway DC, Grierson I, O′Brien C,et al. Adverse effects of topical antiglaucoma medication. Arch Ophthalmol,1994,112:1437-1445.
8Savolainen PS, Jrvinen T, Sasaki KA, et al. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharmaceutical Research,1998,15:1275-1280.
9Schwab IR, Linberg JV, Gioia VM,et al. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology, 1992,99:197-202.
10Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol,2002,86:418-423.
